{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:09:54Z","timestamp":1779336594041,"version":"3.51.4"},"reference-count":32,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8688","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T12:57:45Z","timestamp":1520341065000},"source":"Crossref","is-referenced-by-count":11,"title":["Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts"],"prefix":"10.3892","author":[{"given":"Liping","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui 910\u20111193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Uzui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui 910\u20111193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangyuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui 910\u20111193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"key20200713225116_b1-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: Evidence, mechanisms and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"key":"key20200713225116_b2-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yjmcc.2014.09.016","article-title":"Myocardial matrix metalloproteinase-2: Inside out and upside down","volume":"77","author":"DeCoux","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"key20200713225116_b3-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2143\/AC.62.5.2023412","article-title":"The roles of MMP-2\/TIMP-2 in extracellular matrix remodelling in the hearts of STZ-induced diabetic rats","volume":"62","author":"Li","year":"2007","journal-title":"Acta Cardiol"},{"key":"key20200713225116_b4-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2261-14-150","article-title":"I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"key20200713225116_b5-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200713225116_b6-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2337\/dc14-0315","article-title":"Dapagliflozin's effects on glycemia and cardiovascular risk factors in high-risk patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension","volume":"38","author":"Cefalu","year":"2015","journal-title":"Diabetes Care"},{"key":"key20200713225116_b7-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1517\/14728222.2016.1168808","article-title":"Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus","volume":"20","author":"Song","year":"2016","journal-title":"Exp Opin Ther Targets"},{"key":"key20200713225116_b8-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"e0130605","DOI":"10.1371\/journal.pone.0130605","article-title":"Expression of SGLT1 in human hearts and impairment of cardiac glucose uptake by phlorizin during ischemia-reperfusion injury in mice","volume":"10","author":"Kashiwagi","year":"2015","journal-title":"PLoS One"},{"key":"key20200713225116_b9-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2007.06.067","article-title":"A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia","volume":"360","author":"Banerjee","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713225116_b10-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"e000899","DOI":"10.1161\/JAHA.114.000899","article-title":"Transgenic knockdown of cardiac sodium\/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice","volume":"3","author":"Ramratnam","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key20200713225116_b11-mmr-17-05-6887","first-page":"158","article-title":"Isolation of MMP-2 from MMP-2\/TIMP-2 complex: Characterization of the complex and the free enzyme in pulmonary vascular smooth muscle plasma membrane","volume":"1674","author":"Das","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key20200713225116_b12-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1191\/1352458505ms1193oa","article-title":"Serum MMP-9\/TIMP-1 and MMP-2\/TIMP-2 ratios in multiple sclerosis: Relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment","volume":"11","author":"Avolio","year":"2005","journal-title":"Mult Scler"},{"key":"key20200713225116_b13-mmr-17-05-6887","doi-asserted-by":"crossref","first-page":"61703","DOI":"10.18632\/oncotarget.11225","article-title":"Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713225116_b14-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"key20200713225116_b15-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2017","journal-title":"Diabetologia"},{"key":"key20200713225116_b16-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bbrc.2017.03.127","article-title":"Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats","volume":"486","author":"Zou","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713225116_b17-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/ptr.5777","article-title":"Cryptotanshinone inhibits STAT3 signaling to alleviate cardiac fibrosis in type 1-like diabetic rats","volume":"31","author":"Lo","year":"2017","journal-title":"Phytother Res"},{"key":"key20200713225116_b18-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/aps.2016.72","article-title":"Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"key20200713225116_b19-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"e00417","DOI":"10.1042\/BSR20160346","article-title":"MicroRNA-9 inhibits high glucose-induced proliferation, differentiation and collagen accumulation of cardiac fibroblasts by down-regulation of TGFBR2","volume":"36","author":"Li","year":"2016","journal-title":"Biosci Rep"},{"key":"key20200713225116_b20-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/FJC.0000000000000370","article-title":"Polyphenols and polypeptides in chinese rice wine inhibit homocysteine-induced proliferation and migration of vascular smooth muscle cells","volume":"67","author":"Meng","year":"2016","journal-title":"J Cardiovasc Pharmacol"},{"key":"key20200713225116_b21-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1631\/jzus.BQICC703","article-title":"Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine","volume":"14","author":"Shi","year":"2013","journal-title":"J Zhejiang Univ Sci B"},{"key":"key20200713225116_b22-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.09.015","article-title":"Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK","volume":"65","author":"Siddesha","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"key20200713225116_b23-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/10409238.2010.501783","article-title":"Intracellular substrate cleavage: A novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases","volume":"45","author":"Cauwe","year":"2010","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key20200713225116_b24-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"H764","DOI":"10.1152\/ajpheart.00909.2013","article-title":"MMP-2 is localized to the mitochondria-associated membrane of the heart","volume":"306","author":"Hughes","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20200713225116_b25-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","article-title":"Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy","volume":"124","author":"Westermann","year":"2011","journal-title":"Circulation"},{"key":"key20200713225116_b26-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther"},{"key":"key20200713225116_b27-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"e68617","DOI":"10.1371\/annotation\/457d7567-fc12-421c-9d79-880950ab10e1","article-title":"Delphinidin-3-glucoside protects against oxidized low-density lipoprotein-induced mitochondrial dysfunction in vascular endothelial cells via the sodium-dependent glucose transporter SGLT1","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"key20200713225116_b28-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/cvr\/cvr230","article-title":"NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1","volume":"92","author":"Balteau","year":"2011","journal-title":"Cardiovasc Res"},{"key":"key20200713225116_b29-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"41166","DOI":"10.1038\/srep41166","article-title":"Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart","volume":"7","author":"Van Steenbergen","year":"2017","journal-title":"Sci Rep"},{"key":"key20200713225116_b30-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2017.05.032","article-title":"Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target","volume":"243","author":"Di Franco","year":"2017","journal-title":"Int J Cardiol"},{"key":"key20200713225116_b31-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"key20200713225116_b32-mmr-17-05-6887","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:57:41Z","timestamp":1594681061000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":32,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8688","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]}}}